Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is $4.84. In 2022 the company made an earnings per share (EPS) of $6.83 a decrease over its 2021 EPS that were of $7.92.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $4.84 | -29.11% |
2022 | $6.83 | -13.76% |
2021 | $7.92 | 41.66% |
2020 | $5.59 | -18.91% |
2019 | $6.89 | 21.2% |
2018 | $5.69 | 1125.3% |
2017 | $0.46 | -92.23% |
2016 | $5.97 | 7.37% |
2015 | $5.56 | -4.16% |
2014 | $5.80 | 18.1% |
2013 | $4.91 | 24.88% |
2012 | $3.94 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $3.28 | -32.25% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $5.18 | 6.99% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $3.66 | -24.50% | ๐บ๐ธ USA |
![]() Medtronic MDT | $3.05 | -37.00% | ๐ฎ๐ช Ireland |
![]() Eli Lilly LLY | $6.82 | 40.85% | ๐บ๐ธ USA |
![]() Sanofi SNY | $2.85 | -41.23% | ๐ซ๐ท France |
![]() Gilead Sciences GILD | $4.46 | -7.88% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | $6.93 | 43.14% | ๐บ๐ธ USA |
![]() Merck MRK | $5.73 | 18.35% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $8.03 | 65.91% | ๐ฌ๐ง UK |